Man Group plc Has $24.37 Million Holdings in Oscar Health, Inc. (NYSE:OSCR)

Man Group plc increased its holdings in Oscar Health, Inc. (NYSE:OSCR - Free Report) by 344.8% in the fourth quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 1,813,216 shares of the company's stock after acquiring an additional 1,405,554 shares during the quarter. Man Group plc owned about 0.73% of Oscar Health worth $24,370,000 as of its most recent filing with the Securities & Exchange Commission.

Other institutional investors have also added to or reduced their stakes in the company. Summit Investment Advisors Inc. increased its stake in shares of Oscar Health by 5.8% in the 4th quarter. Summit Investment Advisors Inc. now owns 20,838 shares of the company's stock worth $280,000 after acquiring an additional 1,141 shares during the last quarter. Arizona State Retirement System boosted its position in shares of Oscar Health by 3.1% in the fourth quarter. Arizona State Retirement System now owns 47,918 shares of the company's stock valued at $644,000 after acquiring an additional 1,454 shares during the period. Xponance Inc. lifted its position in Oscar Health by 12.9% during the 4th quarter. Xponance Inc. now owns 14,394 shares of the company's stock valued at $193,000 after purchasing an additional 1,649 shares during the period. KBC Group NV increased its position in shares of Oscar Health by 56.1% in the fourth quarter. KBC Group NV now owns 7,107 shares of the company's stock valued at $96,000 after acquiring an additional 2,555 shares during the last quarter. Finally, Alliancebernstein L.P. boosted its stake in shares of Oscar Health by 1.1% in the 4th quarter. Alliancebernstein L.P. now owns 243,160 shares of the company's stock valued at $3,268,000 after purchasing an additional 2,600 shares in the last quarter. 75.70% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Oscar Health

In other Oscar Health news, Director Elbert O. Jr. Robinson sold 25,000 shares of the business's stock in a transaction on Monday, May 12th. The shares were sold at an average price of $16.43, for a total transaction of $410,750.00. Following the transaction, the director now directly owns 64,512 shares of the company's stock, valued at approximately $1,059,932.16. The trade was a 27.93% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Company insiders own 24.39% of the company's stock.

Wall Street Analysts Forecast Growth

Separately, Wells Fargo & Company cut Oscar Health from an "overweight" rating to an "equal weight" rating and reduced their price target for the stock from $20.00 to $16.00 in a research note on Thursday, March 13th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating, two have given a buy rating and one has given a strong buy rating to the company. According to MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $20.08.

Oscar Health Stock Down 4.6%

OSCR stock traded down $0.80 during midday trading on Monday, hitting $16.72. The stock had a trading volume of 6,184,817 shares, compared to its average volume of 4,206,842. Oscar Health, Inc. has a 52-week low of $11.20 and a 52-week high of $23.79. The company has a debt-to-equity ratio of 0.26, a current ratio of 0.73 and a quick ratio of 0.73. The firm has a market cap of $4.19 billion, a price-to-earnings ratio of -835.58 and a beta of 1.75. The business has a 50-day moving average of $13.46 and a two-hundred day moving average of $14.63.

Oscar Health (NYSE:OSCR - Get Free Report) last announced its quarterly earnings data on Wednesday, May 7th. The company reported $0.92 EPS for the quarter, beating analysts' consensus estimates of $0.83 by $0.09. Oscar Health had a net margin of 0.28% and a return on equity of 2.28%. The company had revenue of $3 billion for the quarter, compared to the consensus estimate of $2.87 billion. During the same period in the prior year, the firm posted $0.62 EPS. The company's quarterly revenue was up 42.2% compared to the same quarter last year. As a group, equities research analysts forecast that Oscar Health, Inc. will post 0.69 earnings per share for the current fiscal year.

Oscar Health Profile

Oscar Health, Inc operates as a health insurance in the United States. The company offers health plans in individual and small group markets, as well as +Oscar, a technology driven platform that help providers and payors directly enable their shift to value-based care. It also provides reinsurance products.